Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis.

Sci Rep · 2021 · PMC7930241 · PMID 33658619

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although using ACEIs/ARBs in COVID-19 patients in general slightly increased the risk of composite severe clinical manifestations (admitted to the ICU/using mechanical ventilation/mortality) but it failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.